At Debiopharm, every step we take is guided by one purpose: improving the lives of people affected by cancer and infectious diseases. As a privately-owned Swiss biopharmaceutical company, we’re driven by science, but above all, by
Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to research in oncology and infectious diseases in order to improve patient outcomes and quality of life. Our main activities include drug development,
At Debiopharm, every step we take is guided by one purpose: improving the lives of people affected by cancer and infectious diseases. As a privately-owned Swiss biopharmaceutical company, we’re driven by science, but above all, by
LIGENTEC is a rapidly growing European deep-tech Process Design House headquartered in Lausanne, Switzerland, with R&D and manufacturing operations in France. We develop, design, manufacture, and test Photonic Integrated Circuits (PICs) for demanding applications in Sensing,
At Debiopharm, every step we take is guided by one purpose: improving the lives of people affected by cancer and infectious diseases. As a privately-owned Swiss biopharmaceutical company, we’re driven by science, but above all, by
Are you a strategic Market Access and HEOR professional ready to shape the commercial and clinical destiny of an innovative pipeline? Debiopharm is seeking a Global Value & Access Lead to define and drive the long-term
Together, we innovate, we impact, we grow ! At Debiopharm, every step we take is guided by one purpose: improving the lives of people affected by cancer and infectious diseases. As a privately-owned Swiss biopharmaceutical company,
Together, we innovate, we impact, we grow ! At Debiopharm, every step we take is guided by one purpose: improving the lives of people affected by cancer and infectious diseases. As a privately-owned Swiss biopharmaceutical company,
Together, we innovate, we impact, we grow At Debiopharm, every step we take is guided by one purpose: improving the lives of people affected by cancer and infectious diseases. As a privately-owned Swiss biopharmaceutical company, we’re
Together, we innovate, we impact, we grow ! At Debiopharm, every step we take is guided by one purpose: improving the lives of people affected by cancer and infectious diseases. As a privately-owned Swiss biopharmaceutical company,